Cargando…
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
There is a need, in NAFLD management, to develop non-invasive methods to detect steatohepatitis (NASH) and to predict advanced fibrosis stages. We evaluated a tool based on optical analysis of liver magnetic resonance images (MRI) as biomarkers for NASH and fibrosis detection by investigating patien...
Autores principales: | Gallego-Durán, Rocío, Cerro-Salido, Pablo, Gomez-Gonzalez, Emilio, Pareja, María Jesús, Ampuero, Javier, Rico, María Carmen, Aznar, Rafael, Vilar-Gomez, Eduardo, Bugianesi, Elisabetta, Crespo, Javier, González-Sánchez, Francisco José, Aparcero, Reyes, Moreno, Inmaculada, Soto, Susana, Arias-Loste, María Teresa, Abad, Javier, Ranchal, Isidora, Andrade, Raúl Jesús, Calleja, Jose Luis, Pastrana, Miguel, Iacono, Oreste Lo, Romero-Gómez, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981860/ https://www.ncbi.nlm.nih.gov/pubmed/27514671 http://dx.doi.org/10.1038/srep31421 |
Ejemplares similares
-
Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance
por: Arias-Loste, María Teresa, et al.
Publicado: (2014) -
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017) -
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022) -
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
por: Ampuero, Javier, et al.
Publicado: (2012) -
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System
por: Dopazo, Joaquín, et al.
Publicado: (2021)